RADIENT PHARMACEUTICALS Corp 5 SEC Filings

Filed On	Filing
17 Feb 2009	Form 5: Ariura Akio, Chief Financial Officer Holds 100,000 shares of Common Stock
17 Feb 2009	Form 5: Maclellan Douglas Charles, Director Holds 201,100 shares of Common Stock
17 Feb 2009	Form 5: Zheng Fang, Director of Jade Capital Holds 700,000 shares of Common Stock
17 Feb 2009	Form 5: Thompson William M. Iii, Director Holds 44,039 shares of Common Stock
17 Feb 2009	Form 5: Jia Minghui, Director Holds 701,000 shares of Common Stock
17 Feb 2009	Form 5: Arquilla Edward R, Director Holds 56,494 shares of Common Stock
14 Feb 2008	Form 5: Jia Minghui, Director Holds 600,000 shares of Common Shares
14 Feb 2008	Form 5: Jade Capital Group Ltd, 10% owner Holds 972,672 shares of Common Stock
14 Feb 2008	Form 5: Maclellan Douglas Charles, Director Holds 100 shares of Common Stock
14 Feb 2008	Form 5: Thompson William M. Iii, Director Holds 3,039 shares of Common Stock
14 Feb 2008	Form 5: Zheng Fang, 10% owner Holds 600,000 shares of Common Shares
14 Feb 2008	Form 5: Dreher Gary L, Director Holds 2,100 shares of Common Stock
14 Feb 2008	Form 5: Arquilla Edward R, Director Holds 14,964 shares of Common Stock
14 Feb 2008	Form 5: Ariura Akio, Chief Financial Officer Holds 40,000 Stock Options (exercise price $3.70, expires Oct 8, 2011)
14 Feb 2007	Form 5: Thompson William M, Director Granted 250,000 Stock Options ($925K)
14 Feb 2007	Form 5: Maclellan Douglas Charles, Director Granted 120,000 Stock Options ($444K)
14 Feb 2007	Form 5: Jia Minghui, Director Holds 600,000 shares of Common Shares
14 Feb 2007	Form 5: Dreher Gary L, Director Granted 200,000 Stock Options ($740K)
14 Feb 2007	Form 5: Arquilla Edward R, Director Granted 20,000 Stock Options ($74K)
14 Feb 2007	Form 5: Jade Capital Group Ltd, 10% owner Holds 1,184,900 shares of Common Stock

Comments